[ET Net News Agency, 25 October 2021] Sinopharm Group Co. Ltd. (01099) said for the
nine months ended 30 September 2021 prepared in accordance with the PRC GAAP, net profit
attributable to equity holders of the parent was RMB5.7 billion, a year-on-year increase
of 14.98%. Basic earnings per share were RMB1.83.
Total operating revenue was RMB381.29 billion, a year-on-year increase of 16.38%. (RC)